ATH: ASX (Australian Securities Exchange)Yes: Ordinary Shares: AU: AUD: Mar 2000: PBN: DB (Deutsche Boerse AG)Yes: Ordinary Shares: DE: EUR: Mar 2000: ATH: CHIA (Chi-X Australia)Yes: Ordinary Shares: … How to Buy Shares in Australia (for beginners), 2. Share prices currently hold above 0.293 critical support level and could head back up to retest 0.394 if it remains above current support. Data supplied by Morningstar on 27 Oct 2020. Incorporated: in VIC on 11/11/1997 as Prana Corporation Pty Ltd. Incorporation status changed to "Limited" on 26/11/1999. Index data is provided © S&P Dow Jones Indices LLC 2020. Alterity Therapeutics (ATH) share price, charts, trades & the UK's most popular discussion forums. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. Alterity Therapeutics Limited (ATH, formerly Prana Biotechnology Limited) is an Australian biotechnology company which focusses to commercialise research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders. Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. All rights reserved. Today’s ATH share price, stock chart and announcements. ATH should find support at the fib retracement ).782 level, rally off it to test and break the fib ext 0.382 level. Click for restrictions. Offical data as published by ASX. All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps). View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer … It's not possible to publish a real-time Top 20 Shareholder list. ATH directors must report any change in shareholding to the ASX within 5 business days. Name changed to Prana Biotechnology Limited on 05/01/2000. Share prices fell sharply following a massive pump in yesterday's trades and closed around critical support at 0.138. Major resistance - 0.394 and 0.490 Join the HotCopper ASX share market forum today for free. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it’s usually once a year in their Annual Report. Stock analysis for Alterity Therapeutics ltd (ATH:ASE) including stock price, stock chart, company news, key statistics, fundamentals and company profile. See the Consensus Data posts for more information. All website content is provided “as is” and not for trading purposes. All rights reserved. Major support - 0.293 and 0.195 profile, My Data is manually extracted from 3Y Announcements. The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". ASX - Short Term Trading ... ATH (ASX… Data is usually extracted from Annual Reports. (ASX:ATH) Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alterity Therapeutics. Latest Posts. Market data is provided and copyrighted by Thomson Reuters and Morningstar. Please choose another, Invalid password: must not contain more than 3 consecutive identical characters, Invalid password: must not contain more than 3 consecutive sequential characters, The password cannot contain the user name, given name, or family name.

Denver Court Records, Osheaga 2019 After Party, Who Dat Nation Images, Sarah Abo Monash University, Beijing Rugby, Colorado Climate Change Predictions, Raiders National Anthem Today, Tornado Touchdown In Texas Today 2020, Lego Duplo My First Race Car,